Yahoo Web Search

Search results

    • This Unpopular Dividend Stock Is a Buy

      This Unpopular Dividend Stock Is a Buy

      Motley Fool via Yahoo Finance· 4 hours ago

      BMS is dealing with the loss of patent protection for its cancer medication Revlimid, which it gained through its acquisition of Celgene in 2019. Here's...

    • Why Trump Could Win the Union Vote

      Why Trump Could Win the Union Vote

      The Wall Street Journal· 1 hour ago

      The powerful nonprofits, green industries and progressive asset managers that set the Democratic agenda welcome such moves. But these measures are ...

    • How Conservatives are Rebranding Pro-Life

      How Conservatives are Rebranding Pro-Life

      Rolling Stone via Yahoo News· 1 hour ago

      Instead, they replaced it with words like “standard” and “consensus.” It makes sense: “I support a national consensus” sounds a whole lot better than “I...